Cost concerns, not the guidelines, drive clinical care of IBD during COVID pandemic in a resource limited setting.

Dear Editor,We read with keen interest the excellent review by Anikhindi et al. regarding the management strategies for inflammatory bowel disease (IBD) in the COVID era [1]. As suggested by the au...